Enhancement of gemcitabine toxicity and specificity through PI3K/Akt/Nrf2 pathway inhibition in pancreatic cancerYu-Shan Chen(Biology of Infection), Philip J. Day(Unknown)Frontiers in PharmacologyFebruary 16, 202610.3389/fphar.2026.1724989Cited by 1SaveCiteExport RISWatch citationsRelated PapersSingle-cell analysis of K562 cells: An imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein|Experimental Hematology|2013|23